KLRS
#3946
Kalaris Therapeutics, Inc. - Common Stock
4.5 1 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.88%
Variación mensual
+2.50%
Variación en los últimos 6 meses
-55.91%
Cambio anual
-55.91%
Cierres anteriores
4.5 5
Open
4.5 1
Mínimo
4.5 1
High
4.5 1
Volumen
1
Financials
- Market Capitalization 107.3 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3942 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.92 USD | +1.10% | +9.52% | +4.55% | -19.30% | 109.81 M USD | ||
| 3943 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.35 USD | +5.02% | +10.20% | +29.84% | +4.04% | 113.98 M USD | ||
| 3955 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.85 USD | -0.54% | -11.48% | +6.94% | -37.29% | 106.01 M USD | ||
| 3958 |  ICCC ImmuCell Corporation - Common Stock | 11.40 USD | -2.73% | +7.85% | +19.75% | +79.81% | 103.13 M USD |